The tweet was deleted by the author.
But we saved everything 🙂.
Intuitive Surgical congratulated MultiCare Tacoma General Hospital and Sharp Healthcare, according to a recent tweet.
The company also tagged Piedmont Health, UI Health Care, and Lee Health in the announcement. Details are being clarified.
ISRG is currently trading at $468.71, positioned below the MA-20 ($486.87), MA-50 ($499.35), and MA-200 ($508.16), which confirms persistent short-term, medium-term, and long-term bearish momentum. The Ichimoku Kijun on D1 sits at $485.01, marking immediate resistance ahead of any rebound attempts. Near-term support is seen at the MA-5/EMA-5 cluster around $474.48–$475.52, while key support is the MA-10/EMA-10 zone around $477.30–$478.27; resistance is defined first by the Ichimoku Kijun at $485.01, with the next major barrier at MA-50 ($499.35).
Momentum indicators continue to signal pronounced selling pressure, as both MACD and ADX on D1 issue sell signals with no divergence from the prevailing trend. Oscillators consistently highlight oversold conditions: D1 RSI is subdued at 36.00, Stoch RSI and CCI both reinforce the oversold state, and BBP’s negative value indicates sellers clearly dominate short-term action. The Awesome Oscillator also supports this bearish bias. ISRG is trading at $468.71, down from $477.81 a week ago, reflecting a 1.90% decline. The price now hovers at the very bottom of its recent weekly range, and weekly volatility stands at 4.41%. This signals a steady decline from the week’s high with no evidence of recovery so far.
Looking ahead, the expected price range for ISRG over the next week is $460 to $478, calibrated to the recent price action and typical volatility. With all W1 trend and momentum indicators—RSI, ADX, MACD, and MA-50—firmly bearish, the probability of a further price decrease is very high (more than 80%), while the likelihood of sustained gains is very low. The baseline scenario sees the price consolidate between $460 and $478. In a bullish outcome, a break above $485 would open the way for short-term recovery targets near $499, though this is unlikely under current momentum. In a bearish scenario, a clean move below $460 would expose ISRG to tests closer to the 52-week low at $425, while any upside is capped well below the 52-week high of $603.88.